Abcellera Biologics Stock Technical Analysis

ABCL Stock  USD 2.97  0.03  1.02%   
As of the 19th of January, Abcellera Biologics shows the risk adjusted performance of 0.0747, and Mean Deviation of 3.19. Abcellera Biologics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Abcellera Biologics jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if Abcellera Biologics is priced correctly, providing market reflects its regular price of 2.97 per share. Please also double-check Abcellera Biologics total risk alpha, which is currently at 0.225 to validate the company can sustain itself at a future point.

Abcellera Biologics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Abcellera, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Abcellera
  
Abcellera Biologics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Abcellera Biologics Analyst Consensus

Target PriceAdvice# of Analysts
12.14Strong Buy9Odds
Abcellera Biologics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Abcellera analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Abcellera stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Abcellera Biologics, talking to its executives and customers, or listening to Abcellera conference calls.
Abcellera Analyst Advice Details
Abcellera Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Abcellera Biologics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Abcellera Biologics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Abcellera Biologics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Abcellera Biologics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Abcellera Biologics Trend Analysis

Use this graph to draw trend lines for Abcellera Biologics. You can use it to identify possible trend reversals for Abcellera Biologics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Abcellera Biologics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Abcellera Biologics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Abcellera Biologics applied against its price change over selected period. The best fit line has a slop of    , which means Abcellera Biologics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.69, which is the sum of squared deviations for the predicted Abcellera Biologics price change compared to its average price change.

About Abcellera Biologics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Abcellera Biologics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Abcellera Biologics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Abcellera Biologics price pattern first instead of the macroeconomic environment surrounding Abcellera Biologics. By analyzing Abcellera Biologics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Abcellera Biologics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Abcellera Biologics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2023 2024 2025 (projected)
Days Sales Outstanding29.02618.0556.2584.01
PTB Ratio2.341.431.651.57

Abcellera Biologics January 19, 2025 Technical Indicators

Most technical analysis of Abcellera help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Abcellera from various momentum indicators to cycle indicators. When you analyze Abcellera charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
When determining whether Abcellera Biologics is a strong investment it is important to analyze Abcellera Biologics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Abcellera Biologics' future performance. For an informed investment choice regarding Abcellera Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.459
Earnings Share
(0.62)
Revenue Per Share
0.112
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.13)
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.